Literature DB >> 24522999

Medication overuse headache in children and adolescents.

Matteo Chiappedi1, Umberto Balottin.   

Abstract

Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522999     DOI: 10.1007/s11916-014-0404-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  49 in total

1.  Analgesic-induced headaches: an unrecognized epidemic.

Authors:  J Edmeads
Journal:  Headache       Date:  1990-09       Impact factor: 5.887

2.  Medication overuse headache: type I and type II.

Authors:  J R Saper; A E Lake
Journal:  Cephalalgia       Date:  2006-10       Impact factor: 6.292

3.  Genomic expression patterns in medication overuse headaches.

Authors:  Andrew D Hershey; Danny Burdine; Marielle A Kabbouche; Scott W Powers
Journal:  Cephalalgia       Date:  2010-06-02       Impact factor: 6.292

4.  Medication overuse headache in school-aged children: more common than expected?

Authors:  Jean-Christophe Cuvellier; Hala Nasser; Louis Vallée
Journal:  Headache       Date:  2013-02       Impact factor: 5.887

5.  Direct-to-consumer drug marketing: public service or disservice?

Authors:  J T Berger; P Kark; F Rosner; S Packer; A J Bennett
Journal:  Mt Sinai J Med       Date:  2001-05

6.  Chronic daily headache in adolescents: an 8-year follow-up study.

Authors:  Shuu-Jiun Wang; Jong-Ling Fuh; Shiang-Ru Lu
Journal:  Neurology       Date:  2009-07-15       Impact factor: 9.910

7.  Chronic daily headache in French children and adolescents.

Authors:  Jean-Christophe Cuvellier; Frédéric Couttenier; Sylvie Joriot-Chekaf; Louis Vallée
Journal:  Pediatr Neurol       Date:  2008-02       Impact factor: 3.372

8.  Medication-overuse headache in children: is initial preventive therapy necessary?

Authors:  Eric H Kossoff; Dhwani N Mankad
Journal:  J Child Neurol       Date:  2006-01       Impact factor: 1.987

9.  Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache.

Authors:  Pernilla Jonsson; Mattias Linde; Gunnel Hensing; Tove Hedenrud
Journal:  J Headache Pain       Date:  2012-03-17       Impact factor: 7.277

10.  Cephalalgiaphobia: a possible specific phobia of illness.

Authors:  Mario F P Peres; Juliane P P Mercante; Vera Z Guendler; Felipe Corchs; Marcio A Bernik; Eliova Zukerman; Stephen D Silberstein
Journal:  J Headache Pain       Date:  2007-02-19       Impact factor: 7.277

View more
  4 in total

Review 1.  Medication-overuse headache: a perspective review.

Authors:  Maria Lurenda Westergaard; Signe Bruun Munksgaard; Lars Bendtsen; Rigmor Højland Jensen
Journal:  Ther Adv Drug Saf       Date:  2016-06-30

Review 2.  Psychological Therapy in Adolescents with Chronic Daily Headache.

Authors:  Matteo Chiappedi; Martina Maria Mensi; Cristiano Termine; Umberto Balottin
Journal:  Curr Pain Headache Rep       Date:  2016-01

3.  Experts' opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta.

Authors:  Aynur Özge; Ishaq Abu-Arafeh; Amy A Gelfand; Peter James Goadsby; Jean Christophe Cuvellier; Massimiliano Valeriani; Alexey Sergeev; Karen Barlow; Derya Uludüz; Osman Özgür Yalın; Noemi Faedda; Richard B Lipton; Alan Rapoport; Vincenzo Guidetti
Journal:  J Headache Pain       Date:  2017-11-29       Impact factor: 7.277

4.  Intellectual Profile of Adolescents with Headache: A Case-Control Study Using the WISC-IV.

Authors:  Matteo Chiappedi; Martina Mensi; Eliana Antonaci; Elena Zavani; Livio Tronconi; Cristiano Termine; Umberto Balottin
Journal:  Front Neurol       Date:  2018-03-06       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.